Milk-alkali syndrome in a middle-aged woman after ingesting large doses of calcium carbonate: a case report by unknown
Case report
Open Access
Milk-alkali syndrome in a middle-aged woman after ingesting large
doses of calcium carbonate: a case report
Mandy Grubb1*, Kumar Gaurav2 and Mukta Panda1
Addresses: 1Department of Medicine, University of Tennessee, College of Medicine, 960 East Third Street, Suite 208, Chattanooga, TN 37403, USA
2Department of Internal Medicine, Division of Nephrology, University of Virginia, Charlottesville, Virginia, USA
Email: MG* - mlgrubb@gmail.com; KG - doctorkumargaurav@yahoo.com; MP - mukta.panda@erlanger.org
*Corresponding author
Received: 7 June 2009 Accepted: 28 August 2009 Published: 16 September 2009
Cases Journal 2009, 2:8198 doi: 10.4076/1757-1626-2-8198
This article is available from: http://casesjournal.com/casesjournal/article/view/8198
© 2009 Grubb et al.; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction: Most cases of hypercalcaemia are secondary to malignancy or primary hyper-
parathyroidism. Here we report a case of hypercalcaemia that we have attributed to milk-alkali
syndrome.
Case presentation: A 51-year-old Caucasian woman with a past history of thyroidectomy and
parathyroidectomy secondary to thyroid cancer developed an altered mental state and had an
extremely high calcium concentration of 22.8 mg/dl (5.7 mmol/l). Investigations included work up for
malignancy and hyperparathyroidism. However, the hypercalcaemia was attributed to ingestion of
large doses of calcium carbonate, leading to milk-alkali syndrome. She was managed with intravenous
fluids and withdrawal of calcium carbonate. The patient responded well to treatment, with
normalization of the calcium concentration and clinical improvement.
Conclusion: We present this case to remind clinicians of the importance of detailed history taking
and of milk-alkali syndrome as a cause of hypercalcemia.
Introduction
Most cases of hypercalcemia are secondary to malignancy
or primary hyperparathyroidism [1]. Milk-alkali syndrome
accounts for about 12% of cases and ranks third among
the causes of hypercalcemia [2] This syndrome is caused
by ingestion of large amounts of calcium along with
absorbable alkali. The occurrence of milk-alkali syndrome
had fallen with the use of non-alkali therapies for peptic
ulcer disease [3]. However, recently the incidence has
increased secondary to the use of calcium carbonate for
the prevention and treatment of osteoporosis and
hyperphosphataemia in patients with chronic kidney
disease [4]. We report a case of milk-alkali syndrome
secondary to ingestion of calcium carbonate.
Case presentation
A 51-year-old Caucasian woman presented with malaise
and generalized weakness for one week and altered mental
status of unknown duration. She was awake, slow to
respond, and disoriented, and a complete history was
unobtainable. Her past medical history included thyroi-
dectomy and radio-iodine therapy 12 years before for a
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Hurthle cell thyroid carcinoma. She had a 30 pack-year
history of smoking. She had been taking levothyroxine for
iatrogenic hypothyroidism and calcium for iatrogenic
hypoparathyroidism, but had been lost to follow-up for
3 years before presentation. She was disoriented and in no
acute distress. Her blood pressure was 149/77 mmHg,
heart rate 59/min, and she had extremely dry mucous
membranes, tenting of the skin, dry scaly skin, right eye
anisocoria, and symmetrical hyporeflexia. The rest of the
physical examination was normal. Her initial laboratory
values are listed in Table 1. She had severe hypercalcaemia,
mild anaemia, renal insufficiency, metabolic alkalosis, and
hypothyroidism. The arterial blood gases confirmed
metabolic alkalosis (pH 7.57, PaCO2 47 mmHg
(6.3 kPa), PaO2 87 mmHg (11.6 kPa), HCO3 43 mmol/l,
98% oxygen saturation on room air). A computerized
tomographic scan of the brain was normal. She responded
well to aggressive intravenous fluid administration and the
calcium concentration fell slowly. She was also given
levothyroxine and corticosteroids. Investigations included
work-up for malignancy, hyperparathyroidism, vitamin D
intoxication, calcium intoxication, and granulomatous
diseases such as sarcoidosis. Because of the extremely
high concentration of calcium,malignancy was high on the
list of differential diagnoses. Protein electrophoresis, chest
X-ray, colonoscopy, esophagoduodenoscopy, and breast
examination were normal. Intact PTH and PTH-related
peptide were undetectable in the serum. The serum
concentration of 1,25(OH)2-Vitamin D was low at 7 pg/
ml. After resolution of her confusion, she admitted to
having consumed 7.2 g (175 mmol) of calcium per day
and confirmed that her anisocoria was congenital. We
therefore attributed her hypercalcaemia to milk-alkali
syndrome, due to excessive intake of calcium carbonate.
Discussion
Symptoms in hypercalcaemia may be secondary to the
raised calcium concentration itself or to the underlying
cause. Hypercalcaemia usually becomes symptomatic at a
concentration of 12-14 mg/dl (3.0-3.5 mmol/l) [5]. The
symptoms are predominantly related to the gastro-
intestinal and renal tracts and the nervous and muscu-
loskeletal systems. These include abdominal pain, reduced
appetite, nephrolithiasis, depressed mood, headache,
confusion, lethargy, and muscle weakness [4]. Of all
cases of hypercalcaemia 80-90% are secondary to malig-
nancy or primary hyperparathyroidism, but many other
disorders can cause hypercalcaemia [1]. A few that are
important to remember include milk-alkali syndrome,
vitamin D intoxication, and granulomatous diseases such
as sarcoidosis. Milk-alkali syndrome is now the third most
common cause and accounts for about 12% of cases [2].
The initial diagnostic work-up for hypercalcaemia includes
serum PTH, phosphorus, 25-OH-cholecalciferol and
1,25 OH2-cholecalciferol, and urinary calcium.
Our patient had profound symptomatic hypercalcaemia,
which caused lethargy, cognitive disturbance, and muscle
weakness. Work-up for malignancy was negative and she
gave a history of calcium and alkali ingestion. The clinical
laboratory data were characteristic of milk-alkali syn-
drome and we excluded other causes of hypercalcemia [6].
In the early 20th century, calcium-containing antacids and
milk were used to treat peptic ulcer disease. Sometimes
this therapy was associated with toxicity [6,7]. Hardt and
Rivers identified the milk-alkali syndrome in 1923 and
reported that it caused headache, nausea, vomiting,
dizziness, musculoskeletal pains, and weakness [7].
Today, this syndrome continues to occur in patients
who have ingested large amounts of calcium, in excess of
4 g/day with absorbable alkali, particularly as calcium
carbonate [4,6]. The milk-alkali syndrome had become
less frequent with the use of non-alkali therapies for peptic
ulcer disease, but the incidence has recently increased,
probably secondary to the use of calcium carbonate for
osteoporosis and hyperphosphataemia in patients with
chronic kidney disease [4].
The pathophysiology of the milk-alkali syndrome is
poorly understood. It is unclear why only some indivi-
duals are affected by excessive ingestion, but it has been
suggested that they absorb more calcium than others [9].
The triad of milk-alkali syndrome includes hypercal-
caemia, metabolic alkalosis, and renal insufficiency [8].
Hypercalcaemia causes reduced glomerular filtration rate,
Table 1. Pertinent laboratory values
Test Patient Values Reference Ranges
Calcium 22.8 mg/dL (5.7 mmol/L) 8.4-10 mg/dL
Albumin 4.6 g/dL (46 g/L) 3.4-4.8 g/dL
Total protein 8.5 g/dL (85 g/L) 6.4-8.3 g/dL
WBC count 10.6 × 109/L 4.8-10.8 × 109/L
Haemoglobin 10.9 g/dL (109 g/L) 12.0-16.0 g/dL
Haematocrit 31.4% (0.314) 37.0-47.0%




Sodium 133 mmol/L 136-145 mmol/L
Potassium 2.6 mmol/L 3.5-5.1 mmol/L
Chloride 93 mmol/L 98-107 mmol/L
Bicarbonate 36 mmol/L 22-29 mmol/L
Blood urea
nitrogen
48 mg/dL 9.8-20.1 mg/dL
Creatinine 2.1 mg/dL (186 µmol/L) 0.5-1.0 mg/dL
Magnesium 1.5 mg/dL (0.62 mmol/L) 1.7-2.2 mg/dL
Phosphate 2.9 mg/dL (0.94 mmol/L) 2.3-4.7 mg/dL
Alkaline
phosphatase
137 U/L 40-150 U/L
TSH 89.8 mIU/mL 0.4-4.0 mIU/mL
Free T4 0.65 ug/dL (8.4 pmol/L) 5.20-12.5 ug/dL
CPK 473 U/L 29-168 U/L
Initial laboratory data showed severe hypercalcaemia, mild anaemia, renal
insufficiency, metabolic alkalosis, and hypothyroidism.
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increased sodium excretion, depletion of total body water,
and suppression of endogenous parathyroid hormone [9].
This leads to increased bicarbonate reabsorption and a
metabolic alkalosis. Alkalosis enhances calcium reabsorp-
tion in the distal nephron, thus aggravating the hypercal-
caemia [9]. This cycle continues as long as calcium and
absorbable alkali are ingested (Figure 1).
The syndrome can present in three ways: acute, subacute,
and chronic. The acute presentation includes weakness,
myalgia, irritability, and apathy. Advanced or chronic
milk-alkali syndrome, otherwise known as Burnett’s
syndrome, involves severe hypercalcaemia, phosphate
retention, and irreversible renal insufficiency. This pre-
sentation can be accompanied by ectopic calcification.
Subacute presentation, as in our patient, causes reversible
renal insufficiency and usually improves over a period of
weeks after withdrawal of oral calcium and alkali.
Conservative treatment and supportive measures such as
intravenous fluids should also be given [6].
Conclusion
In patients with hypercalcaemia, after common causes
such as hyperparathyroidism or malignancy have been
ruled out, it is important to remember the milk-alkali
syndrome as an increasingly common cause of hypercal-
caemia. A detailed history, including the use of over-the-
counter medications, should be taken in all patients [10].
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Figure 1. Pathogenesis physiological explanation for high
amounts of calcium intake as a cause of hypercalcemia.
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